Fig. 2
From: FGF21 is a novel biomarker to predict fragility fractures in patients with type 2 diabetes mellitus
Area under receiver operating characteristic (AuROC) curve for the prediction of fragility fractures in individuals with type 2 diabetes mellitus (T2D). The AuROC of two predictive models for fragility fracture in T2D were compared. The predictive model which was composed of age, gender, BMI-based FRAX-M and AST had AuROC of 0.75. (95% CI 0.64–0.86). With the combination of FGF21 into that predictive model, the AuROC significantly increased from 0.75 to 0.84 (95% CI 0.77–0.91) (AuROC 0.84 VS 0.75, P = 0.023).
